Past Pharmacy Residents
| 2022-2023 | Resident | Project(s) | Post-Grad Activity | Certification |
|---|---|---|---|---|
| 2022-2023 | Sarah El-Koubysi | Diagnostic Patterns of Cefepime-Related Neurotoxicity in Critically-Ill Patients | IBD Pharmacist Specialist SSM Health Oklahoma City, Oklahoma | |
| 2022-2023 | Trevor Sanders | Clinical Outcomes Associated with Beta-Lactam Antibiotic Treatment in Critically Ill Patients with Augmented Renal Clearance | Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma | |
| 2022-2023 | Carley Welch | Minimizing Altered Mental Status: An In-Depth Analysis of Diphenhydramine Dosing in Elderly Patients | Staff Pharmacist Ascension St. John Medical Center Tulsa, Oklahoma | |
| 2021-2022 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2021-2022 | Miranda Brewer | Optimizing Treatment of Beta-Blocker and Calcium Channel Blocker Overdose in the Emergency Department: A Case Series and Review of the Literature | ICU Clinical Pharmacist PGY-2 Critical Care 2022-2023 | |
| 2021-2022 | Leith Prise | The Effects of Liposomal Bupivacaine on Patient Length of Stay and Opioid Use Status Post Colorectal Surgery | Comprehensive Medication Management Pharmacy Specialist INTEGRIS Health Oklahoma City, Oklahoma | BCPS |
| 2021-2022 | Brock Snelson | Revenue Analysis Comparing Reimbursement Rates of Cetuximab and Panitumumab in Patients with EGFR-Positive Metastatic Colorectal Cancer for a Hospital-Based Outpatient Infusion Center | Clinical Pharmacist Baylor Scott & White Temple, Texas | BCPS |
| 2020-2021 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2020-2021 | Michaela Metts | Detailing the Gaps: An In-depth Analysis of Adverse Drug Reaction Surveillance and Reporting in a Community Hospital | Pharmacy Consultant Oklahoma State Department of Health Oklahoma City, Oklahoma Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | MBA, BCPS, AAHIVP |
| 2020-2021 | Cong Vu | Impact of a Pharmacist-Driven Penicillin Skin Testing Protocol in a Community Hospital | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2020-2021 | Charles Whitman | Comparing the Safety and Efficacy of AUC-Based vs. Traditional, Trough Monitoring of Vancomycin in Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia | Clinical Pharmacy Practitioner, Infectious Diseases Central Arkansas Veterans Healthcare System Little Rock, Arkansas PGY-2 Infectious Diseases 2021-2022 U.S. Department of Veterans Affairs Oklahoma City, Oklahoma Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | |
| 2019-2020 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2019-2020 | Jerricah Franz | Pharmacist-driven, fixed-dose, four-factor prothrombin complex concentrate (4F-PCC) protocol for major bleeds | Clinical Pharmacist North Central Baptist Hospital San Antonio, Texas | |
| 2019-2020 | Julia Kaminski | Impact of A Pharmacist Driven Opioid Stewardship Program in An Inpatient Setting | Prescription Drug Monitoring Program Coordinator Clinical Pharmacy Specialist Coatesville VA Medical Center Coatesville, Pennsylvania | |
| 2019-2020 | Emily Deremiah | Impact of a Procalcitonin-Guided Algorithm on Antibiotic Duration in Patients Admitted for Sepsis and Community-Acquired Pneumonia | Critical Care Pharmacist University Health System, San Antonio, Texas PGY-2 Critical Care 2020-2021 University Health System, San Antonio, Texas | BCCCP |
| 2018-2019 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2018-2019 | Danielle Norris (Trierweiller) | Impact of a Pharmacist-driven, AUC-based Therapeutic Drug Monitoring Approach on Outcomes in Patients at High Risk for Vancomycin – related Nephrotoxicity | Clinical Coordinator SSM Health Oklahoma City, Oklahoma | BCPS |
| 2018-2019 | K. Alex Ehrhart | Pharmacy Impact on Narcotic Overrides in a Community Hospital Emergency Department | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2018-2019 | Kathleen Sullivan | Pharmacist Role in Optimization of Programmed Death Ligand (PD-L1) Product Selection Based on Reimbursement Data | Hematology/Oncology Safety Evaluator at the FDA Silver Spring, Maryland PGY 2 Oncology 2019-2020 NorthShore University Health System Chicago, Evanston, Illinois | BCPS |
| 2017-2018 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2017-2018 | Jaclyn Coffey | Impact of Skin Testing for Penicillin Allergy in Self-Reported Penicillin Allergic Patients on the Use of Fluoroquinolones, Carbapenems, Aztreonam and Vancomycin in a Community Hospital | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2017-2018 | Mona Kamali | Impact of a Pharmacist-Driven Probiotic Protocol on the Incidence of Antibiotic- and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Antibiotic Therapy | Clinical Pharmacist Texas Health, Denton, Texas | |
| 2017-2018 | Michael Wisner, Jr. | Evaluating the impact of pharmacy driven interventions on patients with hyperglycemia who have been identified by use of a clinical surveillance software system | Informatics Pharmacist Johns Hopkins Health System, Baltimore, Maryland PGY-2 Informatics 2018-2019 Vanderbilt University, Nashville, Tennessee | |
| 2016-2017 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2016-2017 | Victoria Felder | The Standardization of Admission and Specialty Order Sets to Minimize Duplicate Medication Orders | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2016-2017 | Robert Holliday | Evaluation of the Conversion from Medication Charge on Dispending to Charge on Administration in a Community Hospital | Clinical Pharmacy Specialist Saint John Health System, Tulsa, Oklahoma | BCPS |
| 2016-2017 | Lauren May | Evaluation of Urinary Tract Infection (UTI) Management in a Community Hospital with Subsequent Pathway Development and Implementation | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2015-2016 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2015-2016 | Chris Brown | Shifting from Premixed Nicardipine Injection to Nicardipine Prepared by the Pharmacy: Is It Worth It? | Clinical Pharmacy Specialist and Residency Program Director Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2015-2016 | Jacqueline Medina | Development and Implementation of a Heparin-Induced-Thrombocytopenia Protocol and Implications on Patient Management and Cost | Staff Pharmacist The Hospitals of Providence, El Paso, Texas | BCPS, BCPPS |
| 2015-2016 | Whitney Rohlman | Evaluation of Pyxis Overrides and Development of Policies to Promote Improvement | Director of Pharmacy (2017 – present) Pratt Regional Medical Center, Pratt, Kansas | BCPS |
| 2014-2015 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2014-2015 | Elizabeth Rathgeber | Appropriateness of Iohexol and Iodixanol Use for Prevention of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization | Clinical Pharmacist The Children’s Hospital at OU Medical Center, Oklahoma City, Oklahoma | |
| 2014-2015 | Samantha Sepulveda | Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital | Pharmacist Oklahoma Heart Hospital South, Oklahoma City, OK | |
| 2014-2015 | Lysse Vadder | Analysis and Reduction of Adverse Drug Events Associated with Opioid Use in the Community Hospital Setting | Clinical Pharmacist Integris Bass Baptist Health Center, Enid, Oklahoma | BCPS, SIDP |
| 2013-2014 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2013-2014 | Justin Booth | Impact of Nutrition Support Team Implementation on Parenteral Nutrition Practices in a Community Hospital | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2013-2014 | Kimberly Whitley (Curley) | Development and Implementation of a Standardized Risk Stratification Protocol for Safe Handling of Hazardous Drugs According to NIOSH | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2013-2014 | Minh Truong | War on Pharmaceutical Waste | Institutional Pharmacist Mayo Clinic, Jacksonville, Florida | |
| 2012-2013 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2012-2013 | Shamama Burney | Appropriateness of Acid Suppression Therapy in a Community Hospital | PACT Clinical Pharmacy Specialist Phoenix Veterans Health Care System – Northeast Clinic. Scottsdale, Arzona | |
| 2012-2013 | Sarah Payne | Evaluation and Implementation of a Multi-dose Medication Dispensing at Discharge Policy and Procedure | Chief Operating Officer Health Candi, Inc. PGY2 Residency – Ambulatory Care 2013-2014 University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma | |
| 2012-2013 | Tiffany Sanders (White) | Conversion from Activated Partial Thromboplastin Time (aPTT) to Antifactor Xa Levels for Monitoring of Unfractionated Heparin (UFH) Infusions | PRN Pharmacist St. Anthony Hospital Shawnee, Oklahoma | BCPS |
| 2011-2012 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2011-2012 | Austin Bertram | Development and Evaluation of a Program to Document Pharmacist Order Processing Interventions | Pharmacy Infusion Manager Coram CVS/Specialty Infusion, Oklahoma City, Oklahoma | |
| 2011-2012 | Jenny Stemm | Conversion to Medication Charge upon Administration in a Community Hospital | Manager, Pharmacy Services Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2011-2012 | Karen Thompson | Implementation of Risk Evaluation and Mitigation Strategy (REMS) Requirements and Compliance in the Hospital Setting | Manager of Pharmacy Services and Medication Safety Mercy Health System, Oklahoma City, Oklahoma | BCPS |
| 2010-2011 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2010-2011 | Trevor Knol | Evaluation of Inappropriate Medication Use in Hospitalized Patients Based on the Beers Criteria | Clinical/Staff Pharmacist Oklahoma Heart Hospital, Oklahoma City, Oklahoma | |
| 2010-2011 | Stefanie Stogsdill | Implementation of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency | Clinical Coordinator of Pharmacy Services Northeastern Health System, Tahlequah, Oklahoma | BCPS |
| 2008-2009 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2008-2009 | Jerri Cody | Increasing Pharmacist Review of Medications Prior to Retrieval from Automated Dispensing Cabinets | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | |
| 2008-2009 | Lisa Mayer | Development of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency | Clinical Pharmacist Oklahoma Heart Hospital South, Oklahoma City, Oklahoma | BCPS |
| 2006-2007 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2006-2007 | Lyndsay Sheperd | Trends in Treatment of Clostridium difficile associated Disease in a Community Hospital Setting | Critical Care Pharmacy Specialist PGY2 Residency - Critical Care 2007-2008 | BCPS, BCCCP |
| 2005-2006 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2005-2006 | Emily Lam (Babcock) | Improved Carbapenem Utilization Through Pharmacist Intervention in a Community Hospital Setting | Clinical Pharmacist Deaconess Hospital, Oklahoma City, Oklahoma | |
| 2005-2006 | Debbie Poland | Perioperative Beta-blocker Use in Patients Undergoing Noncardiac Vascular Surgery | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2004-2005 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2004-2005 | Katie Boudreaux (Vandiver) | An Approach to Glycemic Control in a Community Hospital Intensive Care Unit | Director of Pharmacy Services Kindred Hospital, Oklahoma City, Oklahoma | |
| 2022-2023 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2022-2023 | Sarah El-Koubysi | Diagnostic Patterns of Cefepime-Related Neurotoxicity in Critically-Ill Patients | IBD Pharmacist Specialist SSM Health Oklahoma City, Oklahoma | |
| 2022-2023 | Trevor Sanders | Clinical Outcomes Associated with Beta-Lactam Antibiotic Treatment in Critically Ill Patients with Augmented Renal Clearance | Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma | |
| 2022-2023 | Carley Welch | Minimizing Altered Mental Status: An In-Depth Analysis of Diphenhydramine Dosing in Elderly Patients | Staff Pharmacist Ascension St. John Medical Center Tulsa, Oklahoma | |
| 2021-2022 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2021-2022 | Miranda Brewer | Optimizing Treatment of Beta-Blocker and Calcium Channel Blocker Overdose in the Emergency Department: A Case Series and Review of the Literature | ICU Clinical Pharmacist PGY-2 Critical Care 2022-2023 | |
| 2021-2022 | Leith Prise | The Effects of Liposomal Bupivacaine on Patient Length of Stay and Opioid Use Status Post Colorectal Surgery | Comprehensive Medication Management Pharmacy Specialist INTEGRIS Health Oklahoma City, Oklahoma | BCPS |
| 2021-2022 | Brock Snelson | Revenue Analysis Comparing Reimbursement Rates of Cetuximab and Panitumumab in Patients with EGFR-Positive Metastatic Colorectal Cancer for a Hospital-Based Outpatient Infusion Center | Clinical Pharmacist Baylor Scott & White Temple, Texas | BCPS |
| 2020-2021 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2020-2021 | Michaela Metts | Detailing the Gaps: An In-depth Analysis of Adverse Drug Reaction Surveillance and Reporting in a Community Hospital | Pharmacy Consultant Clinical Pharmacist Specialist | MBA, BCPS, AAHIVP |
| 2020-2021 | Cong Vu | Impact of a Pharmacist-Driven Penicillin Skin Testing Protocol in a Community Hospital | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2020-2021 | Charles Whitman | Comparing the Safety and Efficacy of AUC-Based vs. Traditional, Trough Monitoring of Vancomycin in Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia | Clinical Pharmacy Practitioner, Infectious Diseases PGY-2 Infectious Diseases 2021-2022 Clinical Pharmacist Specialist | |
| 2019-2020 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2019-2020 | Jerricah Franz | Pharmacist-driven, fixed-dose, four-factor prothrombin complex concentrate (4F-PCC) protocol for major bleeds | Clinical Pharmacist North Central Baptist Hospital San Antonio, Texas | |
| 2019-2020 | Julia Kaminski | Impact of A Pharmacist Driven Opioid Stewardship Program in An Inpatient Setting | Prescription Drug Monitoring Program Coordinator Clinical Pharmacy Specialist Coatesville VA Medical Center Coatesville, Pennsylvania | |
| 2019-2020 | Emily Deremiah | Impact of a Procalcitonin-Guided Algorithm on Antibiotic Duration in Patients Admitted for Sepsis and Community-Acquired Pneumonia | Critical Care Pharmacist PGY-2 Critical Care 2020-2021 | BCCCP |
| 2018-2019 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2018-2019 | Danielle Norris (Trierweiller) | Impact of a Pharmacist-driven, AUC-based Therapeutic Drug Monitoring Approach on Outcomes in Patients at High Risk for Vancomycin – related Nephrotoxicity | Clinical Coordinator SSM Health Oklahoma City, Oklahoma | BCPS |
| 2018-2019 | K. Alex Ehrhart | Pharmacy Impact on Narcotic Overrides in a Community Hospital Emergency Department | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2018-2019 | Kathleen Sullivan | Pharmacist Role in Optimization of Programmed Death Ligand (PD-L1) Product Selection Based on Reimbursement Data | Hematology/Oncology Safety Evaluator at the FDA PGY 2 Oncology 2019-2020 | BCOP |
| 2017-2018 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2017-2018 | Jaclyn Coffey | Impact of Skin Testing for Penicillin Allergy in Self-Reported Penicillin Allergic Patients on the Use of Fluoroquinolones, Carbapenems, Aztreonam and Vancomycin in a Community Hospital | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2017-2018 | Mona Kamali | Impact of a Pharmacist-Driven Probiotic Protocol on the Incidence of Antibiotic- and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Antibiotic Therapy | Clinical Pharmacist Texas Health, Denton, Texas | |
| 2017-2018 | Michael Wisner, Jr. | Evaluating the impact of pharmacy driven interventions on patients with hyperglycemia who have been identified by use of a clinical surveillance software system | Informatics Pharmacist PGY-2 Informatics 2018-2019 | |
| 2016-2017 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2016-2017 | Victoria Felder | The Standardization of Admission and Specialty Order Sets to Minimize Duplicate Medication Orders | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2016-2017 | Robert Holliday | Evaluation of the Conversion from Medication Charge on Dispending to Charge on Administration in a Community Hospital | Clinical Pharmacy Specialist Saint John Health System, Tulsa, Oklahoma | BCPS |
| 2016-2017 | Lauren May | Evaluation of Urinary Tract Infection (UTI) Management in a Community Hospital with Subsequent Pathway Development and Implementation | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2015-2016 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2015-2016 | Chris Brown | Shifting from Premixed Nicardipine Injection to Nicardipine Prepared by the Pharmacy: Is It Worth It? | Clinical Pharmacy Specialist and Residency Program Director Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2015-2016 | Jacqueline Medina | Development and Implementation of a Heparin-Induced-Thrombocytopenia Protocol and Implications on Patient Management and Cost | Staff Pharmacist The Hospitals of Providence, El Paso, Texas | BCPS, BCPPS |
| 2015-2016 | Whitney Rohlman | Evaluation of Pyxis Overrides and Development of Policies to Promote Improvement | Director of Pharmacy (2017 – present) Pratt Regional Medical Center, Pratt, Kansas | BCPS |
| 2014-2015 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2014-2015 | Elizabeth Rathgeber | Appropriateness of Iohexol and Iodixanol Use for Prevention of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization | Clinical Pharmacist The Children’s Hospital at OU Medical Center, Oklahoma City, Oklahoma | |
| 2014-2015 | Samantha Sepulveda | Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital | Pharmacist Oklahoma Heart Hospital South, Oklahoma City, OK | |
| 2014-2015 | Lysse Vadder | Analysis and Reduction of Adverse Drug Events Associated with Opioid Use in the Community Hospital Setting | Clinical Pharmacist Integris Bass Baptist Health Center, Enid, Oklahoma | BCPS, SIDP |
| 2013-2014 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2013-2014 | Justin Booth | Impact of Nutrition Support Team Implementation on Parenteral Nutrition Practices in a Community Hospital | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2013-2014 | Kimberly Whitley (Curley) | Development and Implementation of a Standardized Risk Stratification Protocol for Safe Handling of Hazardous Drugs According to NIOSH | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2013-2014 | Minh Truong | War on Pharmaceutical Waste | Institutional Pharmacist Mayo Clinic, Jacksonville, Florida | |
| 2012-2013 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2012-2013 | Shamama Burney | Appropriateness of Acid Suppression Therapy in a Community Hospital | PACT Clinical Pharmacy Specialist Phoenix Veterans Health Care System – Northeast Clinic. Scottsdale, Arzona | |
| 2012-2013 | Sarah Payne | Evaluation and Implementation of a Multi-dose Medication Dispensing at Discharge Policy and Procedure | Chief Operating Officer PGY2 Residency – Ambulatory Care 2013-2014 | |
| 2012-2013 | Tiffany Sanders (White) | Conversion from Activated Partial Thromboplastin Time (aPTT) to Antifactor Xa Levels for Monitoring of Unfractionated Heparin (UFH) Infusions | PRN Pharmacist St. Anthony Hospital Shawnee, Oklahoma | BCPS |
| 2011-2012 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2011-2012 | Austin Bertram | Development and Evaluation of a Program to Document Pharmacist Order Processing Interventions | Pharmacy Infusion Manager Coram CVS/Specialty Infusion, Oklahoma City, Oklahoma | |
| 2011-2012 | Jenny Stemm | Conversion to Medication Charge upon Administration in a Community Hospital | Manager, Pharmacy Services Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2011-2012 | Karen Thompson | Implementation of Risk Evaluation and Mitigation Strategy (REMS) Requirements and Compliance in the Hospital Setting | Manager of Pharmacy Services and Medication Safety Mercy Health System, Oklahoma City, Oklahoma | BCPS |
| 2010-2011 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2010-2011 | Trevor Knol | Evaluation of Inappropriate Medication Use in Hospitalized Patients Based on the Beers Criteria | Clinical/Staff Pharmacist Oklahoma Heart Hospital, Oklahoma City, Oklahoma | |
| 2010-2011 | Stefanie Stogsdill | Implementation of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency | Clinical Coordinator of Pharmacy Services Northeastern Health System, Tahlequah, Oklahoma | BCPS |
| 2001-2002 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2008-2009 | Jerri Cody | Increasing Pharmacist Review of Medications Prior to Retrieval from Automated Dispensing Cabinets | Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma | |
| 2008-2009 | Lisa Mayer | Development of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency | Clinical Pharmacist Oklahoma Heart Hospital South, Oklahoma City, Oklahoma | BCPS |
| 2006-2007 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2006-2007 | Lyndsay Sheperd | Trends in Treatment of Clostridium difficile associated Disease in a Community Hospital Setting | Critical Care Pharmacy Specialist PGY2 Residency - Critical Care 2007-2008 | BCPS, BCCCP |
| 2005-2006 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2005-2006 | Emily Lam (Babcock) | Improved Carbapenem Utilization Through Pharmacist Intervention in a Community Hospital Setting | Clinical Pharmacist Deaconess Hospital, Oklahoma City, Oklahoma | |
| 2005-2006 | Debbie Poland | Perioperative Beta-blocker Use in Patients Undergoing Noncardiac Vascular Surgery | Clinical Pharmacy Specialist Norman Regional Health System, Norman, Oklahoma | BCPS |
| 2004-2005 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2004-2005 | Katie Boudreaux (Vandiver) | An Approach to Glycemic Control in a Community Hospital Intensive Care Unit | Director of Pharmacy Services Kindred Hospital, Oklahoma City, Oklahoma | |
| 2003-2004 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2003-2004 | Andrea Chbeir (Phillips) | Evaluation of Fluid Resuscitation in Patients with Sepsis Improving Care of Heart Failure Patients using Quality Performance Indicators | Director of Clinical Services PGY2 Residency - Cardiology 2004-2005 | BCPS |
| 2003-2004 | Brian Hughes | Influencing Meperidine Prescribing Patterns in a Community Hospital Setting | Pharmacy Supervisor PGY2 Pediatrics 2004-2005 | BCPS, BCIDP |
| 2002-2003 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2002-2003 | Cory Whitley | PCA Pump Error Reduction: A Proactive Approach Developing Amphotericin B Usage Guidelines in a Community Hospital Setting | Critical Care Clinical Pharmacist Covenant Health System, Lubbock, TX | BCCCP |
| 2001-2002 | Dana Boyers | Cross-sensitivity of Opioid Analgesics Evaluation of Imipenem Use | Pharmacist US Oncology, Plano, TX | BCOP |
| 2001-2002 | Sheli Kraft | Cross-sensitivity of Beta-lactam Antibiotics Evaluation of Weight-based Heparin Protocol Use | Director of Oncology Pharmacy Services Sisters of Mercy Health System St Louis, Missouri PGY2 Hematology/Oncology |
